RECURSION PHARMACEUTICALS IN

Ticker: RXRX CUSIP: 75629V104 Class: Common Stock

UBS ASSET MANAGEMENT AMERICAS INC's Holding History (CIK: 0000861177)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 4,075,219 Value ($000) $16,668 Avg Close $4.95 Range $3.81 - $7.18
Q3 2025
Shares 4,196,978 Value ($000) $20,481 Avg Close $5.25 Range $4.45 - $7.15
Q2 2025
Shares 4,615,516 Value ($000) $23,355 Avg Close $4.91 Range $3.79 - $6.11
Q1 2025
Shares 6,408,524 Value ($000) $33,901 Avg Close $7.29 Range $5.19 - $12.36
Q4 2024
Shares 2,259,178 Value ($000) $15,272 Avg Close $6.72 Range $5.60 - $9.55
Q3 2024
Shares 2,140,750 Value ($000) $14,108 Avg Close $7.17 Range $5.88 - $8.73
Q2 2024
Shares 2,097,672 Value ($000) $15,733 Avg Close $8.72 Range $6.75 - $10.66
Q1 2024
Shares 205,769 Value ($000) $2,052 Avg Close $11.14 Range $8.68 - $15.74
Q4 2023
Shares 226,873 Value ($000) $2,237 Avg Close $7.13 Range $4.97 - $11.17
Q3 2023
Shares 211,576 Value ($000) $1,619 Avg Close $9.98 Range $6.44 - $16.75
Q2 2023
Shares 115,278 Value ($000) $769 Avg Close $7.00 Range $4.54 - $10.45
Q1 2023
Shares 115,278 Value ($000) $769 Avg Close $7.93 Range $6.40 - $9.73
Q4 2022
Shares 106,931 Value ($000) $824 Avg Close $9.81 Range $7.04 - $13.29
Q3 2022
Shares 76,879 Value ($000) $817,993 Avg Close $10.13 Range $7.48 - $14.18
Q2 2022
Shares 51,453 Value ($000) $418,827 Avg Close $6.69 Range $4.92 - $9.40
Q1 2022
Shares 48,194 Value ($000) $345,069 Avg Close $10.63 Range $5.80 - $18.23
Q4 2021
Shares 35,453 Value ($000) $607,310 Avg Close $18.82 Range $15.25 - $23.86